Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC.

Bo ChenJian-Xiong WuShu-Hui ChengLi-Ming WangWei-Qi RongFan WuShu-Lian WangJing JinYue-Ping LiuYong-Wen SongHua RenHui FangYuan TangNing LiYe-Xiong LiWei-Hu Wang

Published in: Hepatology (Baltimore, Md.) (2021)

Adjuvant radiotherapy is an effective, well-tolerated, and promising adjuvant regimen in patients with HCC who have undergone narrow-margin hepatectomy. Our trial provides evidence and a rationale for planning a future phase 3 trial.

Keyphrases

early stage
clinical trial
locally advanced
liver metastases
radiation induced
study protocol
randomized controlled trial
squamous cell carcinoma
current status
phase ii